Comprehensive assessment of expression of insulin signaling pathway components in subcutaneous adipose tissue of women with and without polycystic ovary syndrome

Journal of Clinical and Translational Endocrinology

Volumn 2, Issue 3, 2015, Pages 99-104

  Xu, Ning ^a   Geller, David H ^a,b   Jones, Michelle R ^a   Funari, Vincent A ^a   Azziz, Ricardo ^c   Goodarzi, Mark O ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Adipose tissue; Gene expression; Insulin signaling pathway; PCOS

Indexed keywords

AKT1 PROTEIN; AKT3 PROTEIN; GLUCOSE; GLUCOSE TRANSPORTER 4; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; H RAS PROTEIN; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; INSULIN SIGNALING PROTEIN; K RAS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PEPTIDES AND PROTEINS; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PRASTERONE SULFATE; PROTEIN KINASE B BETA; PROTEIN SERINE THREONINE KINASE; RAF PROTEIN; SOS PROTEIN; TESTOSTERONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN BINDING; INSULIN RESISTANCE; INSULIN SIGNALING PATHWAY; MITOGENESIS; OVARY POLYCYSTIC DISEASE; SIGNAL TRANSDUCTION; STEROIDOGENESIS; SUBCUTANEOUS FAT; TESTOSTERONE BLOOD LEVEL;

EID: 84937217866     PISSN: None     EISSN: 22146237     Source Type: Journal    
DOI: 10.1016/j.jcte.2015.06.002     Document Type: Article

References (35)

1. M.O. Goodarzi, D.A. Dumesic, G. Chazenbalk, and R. Azziz Polycystic ovary syndrome: etiology, pathogenesis and diagnosis Nat Rev Endocrinol 7 2011 219 231
2. J.E. Nestler, L.P. Powers, D.W. Matt, K.A. Steingold, S.R. Plymate, R.S. Rittmaster, and et al. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome J Clin Endocrinol Metab 72 1991 83 89
3. T. Tang, J.M. Lord, R.J. Norman, E. Yasmin, and A.H. Balen Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility Cochrane Database Syst Rev 5 2012 CD003053
4. R.S. Legro, R. Bentley-Lewis, D. Driscoll, S.C. Wang, and A. Dunaif Insulin resistance in the sisters of women with polycystic ovary syndrome: association with hyperandrogenemia rather than menstrual irregularity J Clin Endocrinol Metab 87 2002 2128 2133
5. M. Simoni, C.B. Tempfer, B. Destenaves, and B.C. Fauser Functional genetic polymorphisms and female reproductive disorders: part I: polycystic ovary syndrome and ovarian response Hum Reprod Update 14 2008 459 484
6. M.O. Goodarzi, Y.V. Louwers, K.D. Taylor, M.R. Jones, J. Cui, S. Kwon, and et al. Replication of association of a novel insulin receptor gene polymorphism with polycystic ovary syndrome Fertil Steril 95 2011 1736 1741.e1-11
7. A. Ioannidis, E. Ikonomi, N.L. Dimou, L. Douma, and P.G. Bagos Polymorphisms of the insulin receptor and the insulin receptor substrates genes in polycystic ovary syndrome: a Mendelian randomization meta-analysis Mol Genet Metab 99 2010 174 183
8. S. Tucci, W. Futterweit, E.S. Concepcion, D.A. Greenberg, R. Villanueva, T.F. Davies, and et al. Evidence for association of polycystic ovary syndrome in Caucasian women with a marker at the insulin receptor gene locus J Clin Endocrinol Metab 86 2001 446 449
9. M. Urbanek, R.S. Legro, D.A. Driscoll, R. Azziz, D.A. Ehrmann, R.J. Norman, and et al. Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin Proc Natl Acad Sci U S A 96 1999 8573 8578
10. Y. Shi, H. Zhao, Y. Cao, D. Yang, Z. Li, B. Zhang, and et al. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome Nat Genet 44 2012 1020 1025
11. J.M. Lizcano, and D.R. Alessi The insulin signalling pathway Curr Biol 12 2002 R236 R238
12. M. Corton, J.I. Botella-Carretero, A. Benguria, G. Villuendas, A. Zaballos, J.L. San Millan, and et al. Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome J Clin Endocrinol Metab 92 2007 328 337
13. M.S. Alebic, T. Bulum, N. Stojanovic, and L. Duvnjak Definition of insulin resistance using the homeostasis model assessment (HOMA-IR) in IVF patients diagnosed with polycystic ovary syndrome (PCOS) according to the Rotterdam criteria Endocrine 47 2014 625 630
14. N. Abate, A. Garg, R.M. Peshock, J. Stray-Gundersen, and S.M. Grundy Relationships of generalized and regional adiposity to insulin sensitivity in men J Clin Invest 96 1995 88 98
15. D. Tuvdendorj, M. Chandalia, T. Batbayar, M. Saraf, C. Beysen, E.J. Murphy, and et al. Altered subcutaneous abdominal adipose tissue lipid synthesis in obese, insulin-resistant humans Am J Physiol Endocrinol Metab 305 2013 E999 E1006
16. G. Chazenbalk, Y.H. Chen, S. Heneidi, J.M. Lee, M. Pall, Y.D. Chen, and et al. Abnormal expression of genes involved in inflammation, lipid metabolism, and Wnt signaling in the adipose tissue of polycystic ovary syndrome J Clin Endocrinol Metab 97 2012 E765 E770
17. Z.H. Huang, B. Manickam, V. Ryvkin, X.J. Zhou, G. Fantuzzi, T. Mazzone, and et al. PCOS is associated with increased CD11c expression and crown-like structures in adipose tissue and increased central abdominal fat depots independent of obesity J Clin Endocrinol Metab 98 2013 E17 E24
18. T. Tao, S. Li, A. Zhao, Y. Zhang, and W. Liu Expression of the CD11c gene in subcutaneous adipose tissue is associated with cytokine level and insulin resistance in women with polycystic ovary syndrome Eur J Endocrinol 167 2012 705 713
19. Y.H. Chen, S. Heneidi, J.M. Lee, L.C. Layman, D.W. Stepp, G.M. Gamboa, and et al. miRNA-93 inhibits GLUT4 and is overexpressed in adipose tissue of polycystic ovary syndrome patients and women with insulin resistance Diabetes 62 2013 2278 2286
20. M.R. Jones, G. Chazenbalk, N. Xu, A.K. Chua, T. Eigler, E. Mengesha, and et al. Steroidogenic regulatory factor FOS is underexpressed in polycystic ovary syndrome (PCOS) adipose tissue and genetically associated with PCOS susceptibility J Clin Endocrinol Metab 97 2012 E1750 E1757
21. W. Chang, M.O. Goodarzi, H. Williams, D.A. Magoffin, M. Pall, and R. Azziz Adipocytes from women with polycystic ovary syndrome demonstrate altered phosphorylation and activity of glycogen synthase kinase 3 Fertil Steril 90 2008 2291 2297
22. R. Azziz, K.S. Woods, R. Reyna, T.J. Key, E.S. Knochenhauer, and B.O. Yildiz The prevalence and features of the polycystic ovary syndrome in an unselected population J Clin Endocrinol Metab 89 2004 2745 2749
23. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method Methods 25 2001 402 408
24. Y.L. Chu, H.Y. Qiu, Y.Y. Sun, M. Li, and H.F. Li Detection and significance of phosphatidylinositol 3-kinase in adipose tissue of polycystic ovary syndrome patients with insulin resistance Zhonghua Fu Chan Ke Za Zhi 41 2006 455 458
25. T.P. Ciaraldi, V. Aroda, S. Mudaliar, R.J. Chang, and R.R. Henry Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance J Clin Endocrinol Metab 94 2009 157 163
26. A. Corbould, and A. Dunaif The adipose cell lineage is not intrinsically insulin resistant in polycystic ovary syndrome Metabolism 56 2007 716 722
27. D. Rosenbaum, R.S. Haber, and A. Dunaif Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes Am J Phys 264 1993 E197 E202
28. Y.L. Chu, Y.Y. Sun, H.Y. Qiu, and H.F. Li Tyrosine phosphorylation and protein expression of insulin receptor substrate-1 in the patients with polycystic ovary syndrome Zhonghua Fu Chan Ke Za Zhi 39 2004 176 179
29. W.J. Ryves, and A.J. Harwood The interaction of glycogen synthase kinase-3 (GSK-3) with the cell cycle Prog Cell Cycle Res 5 2003 489 495
30. G. Pearson, F. Robinson, T. Beers Gibson, B.E. Xu, M. Karandikar, K. Berman, and et al. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions Endocr Rev 22 2001 153 183
31. P.R. Manna, and D.M. Stocco The role of specific mitogen-activated protein kinase signaling cascades in the regulation of steroidogenesis J Signal Transduct 2011 2011 821615
32. J. Cheng, S.C. Watkins, and W.H. Walker Testosterone activates mitogen-activated protein kinase via Src kinase and the epidermal growth factor receptor in sertoli cells Endocrinology 148 2007 2066 2074
33. A. Corbould, H. Zhao, S. Mirzoeva, F. Aird, and A. Dunaif Enhanced mitogenic signaling in skeletal muscle of women with polycystic ovary syndrome Diabetes 55 2006 751 759
34. E.D. Rosen, and O.A. MacDougald Adipocyte differentiation from the inside out Nat Rev Mol Cell Biol 7 2006 885 896
35. F. de Zegher, A. Lopez-Bermejo, and L. Ibanez Adipose tissue expandability and the early origins of PCOS Trends Endocrinol Metab 20 2009 418 423